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ackground: Hepatorenal dysfunction in liver cirrhosis is a condition in which there is progressive 
kidney failure. It is a serious complication that can lead to death. Endothelin is an endothelial cell-
derived peptide which is involved in renal dysfunctioning by generating oxidative stress in 
individuals suffering from liver cirrhosis. It can be used as important biomarker of hepatorenal 
dysfunction. The present study was aimed to detect endothelin-2 in the blood of patients of liver cirrhosis 
with ascites as important biomarker correlated to the generation of oxidative stress and renal 
dysfunctioning.   
Methods: 50 blood and ascitic fluid samples were collected from the patients of liver cirrhosis with ascites 
as case group and 25 from normal individuals as control group. Endothelin-2 was detected by PCR in 
serum and ascetic fluid of patients and its quantification was done by Real-time PCR. ET-2 was quantified 
in serum samples but was not quantifiable in ascetic fluid might be due to its very low concentration. Blood 
urea, creatinine and uric acid with GFR were estimated as renal dysfunction parameters. Anti-oxidative 
enzymes glutathione (GSH), catalase (CAT), superoxide dismutase (SOD) and malondialdehyde (MAD) 
as biomarkers of oxidative stress were estimated in order to calculate oxidative stress. The obtained data 
was evaluated statistically by using t-test and Pearson correlation. 
Results: Positive correlation was found between individual parameters of oxidative stress and renal 
dysfunction. Overall positive and highly significant (P<0.05) correlation of CAT, SOD, MDA, GSH levels 
with each other was observed, a significant (P<0.05) and positive correlation of oxidative stress parameters 
were found with urea, creatinine and uric acid with Glomerular filtration rate (GFR). 
Conclusions: It was concluded that the production of ET-2 under oxidative stress generates renal 
dysfunction in patients of liver cirrhosis with ascites. 
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Introduction  
Renal failure (RF) is a challenging complication of liver 
cirrhosis. It is associated with a high morbidity and 
mortality in patients suffering from liver disease. Its 
incidence is 30% in liver cirrhosis with infections, 11% 
in upper GI bleed and 45 - 50% in critically ill liver 
cirrhosis patients admitted to intensive care units [1]. 
Endothelial dysfunction and the bioavailability of nitric 
oxide (NO) have been documented as one of many risk 
factors for renal problems [2]. Endothelin is a group of 
effective vasoconstrictors peptides that are released from 
vascular endothelial cells and behave as autocrine or 
paracrine regulators. The endothelin system is necessary 
for maintenance of normal blood pressure and 
regulation of vascular tone. There are three isoforms of 
endothelin, endothelin-1 (ET-1), endothelin-2 (ET-2), 
endothelin-3 (ET-3) which are produced in several 
tissues to carry out vasomotor tone, cell proliferation, 
and hormone production [3, 4]. ET-2 is present 
abundantly in kidney and intestine, while a small 
amount is also observed in myocardium cells, placenta, 
and uterus [5]. 
Endothelin performs its action through its receptors: 
(ETA) and (ETB) receptors. These receptors are G 
protein coupled transmembrane proteins with different 
molecular and pharmacological characteristics [6, 7]. 
Endothelin peptide with 31 amino acids has been 
identified in humans, formed through the cleavage of 
the big endothelin-1 between the Tyr31 and Gly32 amino 
acids by a human chymase enzyme expressed in mast 
cells [8].  
The overall function of endothelin is to increase blood 
pressure and vascular tone [9]. Endothelins are proteins 
that constrict blood vessels. They are normally kept in 
balance by other mechanisms; however, when they are 
ove rexpressed, they contribute to high oxidative stress 
and renal disease. ET production is stimulated in a 
variety of different cell types under the influence of risk 
factors for vascular stress leading to renal dysfunction In 
patients of liver cirrhosis with ascites there is induced 
production of oxidative stress with the production of 
endothelins. Portal hypertension is produced due to 
vasoconstriction. Splanchnic vascular and peripheral 
arterial vasodilation takes place which generates nitric 
oxide (NO overproduction). In cirrhosis arteriolar 
vasodilation causes under filling systemic arterial 
vascular space. This event, a decrease in effective blood 
volume leads to a drop in arterial pressure which 
consequently affects glomerular filteration rate in 
kidneys altering renal functions [3]. 
Keeping in view the role of endothelin 2 in generating 
renal complications in liver cirrhosis, the present study 
was conducted to estimate Endothelin-2 as a novel 
biomarker of cardiovascular stress in patients with liver 
cirrhosis.  
Methods 
Total 50 samples of Human sera and ascitic fluid were 
obtained from patients of liver cirrhosis with ascites 
from General Hospital Lahore Pakistan, after approval 
of the protocol by the Ethics Review Committee of 
hospital, along with blood samples of normal 
individuals. Blood samples were processed to get serum 
by centrifugation at 3000 rpm for 10 minutes. All the 
samples were stored at -20oC until further use. 25 
samples of blood and 25 ascetic fluids were taken from 
the patients of liver cirrhosis with ascites randomly. 25 
blood samples were collected from normal individuals. 
The samples were processed and analyzed for the 
detection of ET-2, SOD, GSH, CAT, MDA and NO. 
Blood urea, creatinine and uric acid with GFR were 
estimated as renal dysfunction parameters. Patients with 
hypertension, diabetes, CVD, and pregnant women 
were excluded from the study. 
Detection of ET-2 by Genotyping of serum and ascitic 
fluid  
A multiplex PCR was employed to genotype the serum 
and ascitic fluid specimen. RNA was extracted from 
serum and ascitic fluid samples by using RNA isolation 
Kit Cat No: FAVK001-2 provided by Favorgen Biotech 
Corp, according to the kit protocol with little 
modification. 570 μl of VNE (carrier RNA added) was 
added to the serum and ascitic fluid samples, after 
vortexing incubated for 10 minutes at room temperature 
570 μl of ethanol (96-100%) was transferred to samples. 
500 μl of wash buffer 1 (ethanol) was added to VNE 
column, and was centrifuged at 8000 rpm for 1 minute. 
Then 50 μl of wash buffer 2 (ethanol added) was added 
to VNE column and was centrifuged at 8000rpm for 1 
min before discarded the flow-through. Whole sample 
mixture was centrifuged at full speed 13,000 rpm for 1 
minute. 50 μl of RNase-free water was transferred to 
membrane center of VNE column to elute nucleic acid 
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for 2 minutes and nucleic acid was stored at -70oC. 
Amplification conditions  
For ET-2, primers were designed by primer 3 software 
(Table 1). After reconstitution of primers PCR reaction 
was carried out in thermal cycler with Taq DNA 
polymerase (5U). 
Table 1: Primer used in this study for molecular detection of ET-2 
through PCR 
The amplification was performed with 2 μl of cDNA by 
using 7.8 μl first round PCR mix. 8 μl reaction mixture 
was added to form 10 μl total reaction. Cycling 
condition for amplification of ET-1 and ET-2 was kept 
same. With 35 cycles at 50 oC 7 μl Mix 2 of ET-1, 1μl taq 
(2U) and 2 μl of template was carried out. In 2nd Round 
of Amplification of ET-3 7.8 μl Mix 2 of ET-3, 0.2 μl Taq 
(5U) and 2 μl of template was added and reaction was 
carried at 54 with 35 cycles. Detection of PCR 
amplification products (ET-1 and ET-3) was detected on 
2% agarose gel.  
Quantification of ET-2 
Reaction mixture was prepared by adding 12.5 μl SYBET 
Green, 2.5 μl, Forward Primer 10 (pm/μl), 2.5 μl Reverse 
Primer, 2.5 μl water (nuclease-free) and 5μl cDNA. 
Master mix was mixed thoroughly. For ET-2 in Stage 1 
at 95oC for 600 seconds and in stage 2:3 95.0oC for 15 
seconds, 50.0oC for 30 seconds and 72.0oC for 30 
seconds, thermal conditions were applied.  
Estimation of MDA through standard curve by using 
Thiobarbituric acid (TBARS) 
 Thiobarbituric acid reactive substance was used for 
estimation of MDA level in serum and ascitic fluid. 1 ml 
of both samples was taken and a 10% (w/v) homogenate 
was prepared in 10 mM buffer (pH 7.4). The supernatant 
was used for immediate thiobarbituric acid reactive 
substances. In this test 200 µl of serum sample, 200 µl of 
8.1% sodium dodecyl sulfate (SDS), 1.5 ml of 0.8% TBA, 
1.5 ml of 20% acetic acid solution (pH 3.5) 4.0 ml 
distilled water and 5.0 ml of n-butanol were used. Its 
absorbance at 532 nm was recorded.  
Estimation of SOD, catalase and glutathione activity 
through standard curve  
Serum and ascitic fluid were taken and homogenate was 
prepared in 50% TCA and centrifuged at 13000 rpm. 
The supernatant was used for immediate SOD and other 
enzyme activity evaluation. In this test 100 µl of serum 
sample,1.2 ml of sodium phosphate buffer (pH 8.3, 
0.052M),100 µl of phenazinemethosulphate (186µm), 
300 µl of nitro blue tetrazolium (300 µm), 200 µl of 
NADH (750 µm) and 4.0 ml of nbutanol were used. 
Reaction was started by addition of NADH. .Its 
absorbance at 560 nm was recorded against butanol. All 
procedure for estimation of antioxidant enzyme 
superoxide dismutase was performed in ice bath. 
Catalase activity was measured by the method earlier 
described by Aebi [10]. 1 ml of serum and ascitic fluid 
was taken and a 10% (w/v) homogenate was prepared in 
10 mM buffer (pH 7.4) and was centrifuged at 13,000 
rpm for 10 minutes at 4. The supernatant was used for 
the estimation of CAT. 100 µl of supernatant and 1.9 ml 
of 50mM phosphate buffer and freshly prepared 30 mM 
H2O2 were used. The rate of decomposition of H2O2 was 
measured spectrophotometer at 240 nm. Activity of 
catalase was expressed as unit/ml of protein. 0.1 ml of 
both samples (serum and ascitic fluid) was added in test 
tubes. 2.4 ml of 0.02M EDTA was added in each test tube 
and was kept in ice bath for 10 minutes. Then 2.0 ml of 
dH2O (distilled water) was added in each test tube. After 
addition of dH2O 0.5 ml 50% TCA was added in each 
test tube and was again kept in ice bath for 10-15 
minutes. The mixture was centrifuged at 3000-3500 rpm 
for 10 minutes. 1.0ml supernatant was taken in separate 
tubes and 2.0 ml 5 M Tris HCl and 0.05 ml DTNB was 
added. The mixture was vortexed and absorbance was 
taken after 2-3 minutes at 412 nm. The absorbance was 
compared with standard curve generated by the known 
GSH level. The GSH was measured in µg/ml. 
Estimation of renal parameters 
Creatinine in Serum 
Creatinine estimation was done by buffered kinetic Jaffe 
reaction without deproteization [11]. Concentration of 
creatinine was calculated as follows;
Primer 
Name 
primer  
size (bp) 
OS-E2UL  20 
OAS-E2UL 20 
IS-E2UL 18 
IAS-E2UL 
 Sequence  5/-3/ 
TTGGACATCATCTGGGTGAA 
AAATGTCCACTGAGGCACCA 
CCT TACGGCCTGGGAAAC 
GCA GCAGAGAGGGAGCAG 18 
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Creatinine (mg/dl) = (A sample / A standard) × 2.  
The normal reference value of creatinine in serum, 
plasma is 0.2-1.2 mg/dl. 
Estimation of urea in serum 
Urea was estimated in serum of patients through 
Randox enzymatic kit method [12]. Concentration of 
urea was calculated as follows 
Urea (mg/dl) = (A sample / A standard) × 40  
The normal reference value of urea in serum, plasma is 
14-40 mg/dl  
Estimation of uric acid in serum 
Uric acid was estimated through Randox enzymatic kit 
method [13]. Concentration of uric acid in serum was 
calculated as follows  
Concentration of uric acid in serum (mg/dl) = (A sample 
/ A standard) × 10 and normal reference value in serum 
/ plasma (males): 3.4 – 7.0 mg/dl, and in females: 2.5-6.0 
mg/dl. 
Estimation of GFR 
GFR in male    =    (140 – age) × mass (kg) × 1.23                 
                                   Serum creatinine (µmol/ l) 
GFR in female =    (140 – age) × mass (kg) × 1.04                 
                                   Serum creatinine (µmol/ l) 
Normal reference value: 100 – 130 ml/min/1.73m2 
Statistically designing and data analysis  
The obtained data was evaluated statistically by using t-
test and Pearson correlation. 
Results 
Detection of ET-2 
Total 25 samples of blood and 25 ascitic fluid were taken 
from patients of liver cirrhosis with ascites. RNA was 
extracted from blood and ascitic fluid, cDNA synthesis, 
and PCR amplification of ET-2 gene was done and 
bands were detected in samples of ascitic fluid and 
serum.  
Detection of ET-2 in blood and ascetic fluid 
         
Figure 1: Gel photograph of PCR product showing endothelin-2 (ET-
2) in serum and ascetic fluid. Sample 1-10 (ET-2 in ascetic fluid 
samples), 11 (control positive), 12 (control negative), unnamed 
(Ladder), 13-20 (ET-2 in serum samples). 2% agarose gel showing 
cDNA amplified with ET-2 in ascetic fluid and serum with specific 
primers. The amplified fragments resulted to be of the expected size, 
which was 385 bp for ET-2. 
Quantification of ET-2 gene in serum and ascitic fluid 
ET-2 was quantified in serum samples but was not 
quantifiable in ascetic fluid might be due to its very low 
concentration. ET-2 in serum samples was quantified at 
Ct= 295.5, 33.30, 34.63. Amount of ET-2 was calculated 
by WHO standards amounting 59726.7 cps/μl, 4311.9 
cps/μl and 315.9 cps/μl. 
*(P<0.05) 
Table 2: Estimation of oxidative stress (serum of cirrhotic patients Vs 
fluid of cirrhotic patients) 
The mean value of serum catalase (U/dl) level in normal 
individuals was recorded as 164±10.86 and 142±10.59 in 
patients of liver cirrhosis with ascites (Table 2). 
Significant (P<0.05) reduced level of serum catalase was 
observed in patients of liver cirrhosis as compared to 
control group. Mean SOD (U/dl) levels in normal 
individuals were measured as 9.55±2.21 while in 
patients of liver cirrhosis with ascites it was assessed as 
7.91±2.03. The SOD levels were significantly decreased 
(P<0.05) in patients of liver cirrhosis with ascites as 
compared to control group. Significant decreased levels 
(P<0.05) of GSH were observed in patients of liver 
cirrhosis with ascites 3.96±1.39 as compared to control 
Parameter Group Mean Std. 
deviation 
Std. 
Error 
Mean 
Significance 
CAT (U/dl) Normal 164 10.86 3.13 0.000* 
Patients 142 10.59 2.11 0.000* 
SOD (U/dl) Normal 9.55 2.21 0.63 0.033* 
Patients 7.91 2.03 0.41 0.043* 
GSH (U/dl) Normal 9.96 2.48 0.71 0.000* 
Patients 3.95 1.39 0.28 0.000* 
MDA (U/dl)  Normal 3.68 1.22 0.35 0.000* 
Patients 5.41 1.16 0.23 0.000* 
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group 9.96±2.48. MDA (U/dl) levels in patients of liver 
cirrhosis with ascites were observed as 5.41±1.16 as 
compared to control group 3.68±1.22. The MDA levels 
were significantly increased (P<0.05) in patients as 
compared to control group. 
Parameter Group Mean  Std. 
Deviation 
Std. 
Error 
Mean 
Sig. 2 
tailed 
CAT 
(U/dl) 
Serum 143 10.59 2.11 0.000 
Fluid 119 13.68 2.73 0.000 
SOD 
(U/dl) 
Serum 7.91 2.03 0.41 0.165 
Fluid 7.03 2.34 0.47 0.165 
GSH 
(U/mg)          
Serum 3.95 1.39 0.28 0.150 
Fluid 3.39 1.32 0.26 0.150 
MDA 
(U/dl) 
Serum 5.41 1.16 0.23 0.000 
Fluid 4.05 1.22 0.24 0.000 
Table 3: Estimation of oxidative stress (serum of cirrhotic patients Vs 
fluid of cirrhotic patients) 
The mean values of Catalase (U/dl) in serum and ascetic 
fluid of patients were evaluated as 143±10.59 and 
119±13.69 respectively (Table 3). The significant 
increased (P<0.05) catalase level was observed in serum 
as compared to ascetic fluid of patients of liver cirrhosis 
with ascites. The insignificantly elevated mean values 
(P>0.05) of SOD (U/dl) were observed as 7.91±2.03 in 
serum as compared to ascetic fluid 7.03±2.349. The 
mean values of GSH (U/dl) in patient’s serum were 
estimated as 3.95±1.39 and where in ascetic fluid it was 
3.39±1.32. Insignificant difference was observed in GSH 
levels in serum as compared to ascetic fluid of patients 
of liver cirrhosis with ascites. The MDA (U/dl) levels in 
serum patients were observed as 5.41±4.05 as compared 
to ascetic fluid of patients 4.05±1.22. The MDA levels 
were significantly (P<0.05) elevated in serum as 
compared to ascetic fluid. 
Estimation of Renal Parameters 
According to descriptive statistics the mean values of 
urea in control and renal failure patients were ±15.2 and 
±57.37 respectively (Table 4). The observed mean values 
of creatinine in control group were ± 0.90 while in renal 
failure patients were ±2.28. Similarly uric acid in control 
group was observed ± 3.90 while in renal failure patient. 
The observed mean values of uric acid in renal failure 
patients were ±16.89. The observed mean values of GFR 
in control group were ±119.8 while in renal failure 
patients were ±53.44. According to independent T test, 
overall significant difference was observed in all the 
renal parameters (Urea, Creatine, Uric acid and GFR) of 
renal failure patients as compared to control group. 
By using Pearson correlation (Table 5), the significant 
positive (P<0.05) correlation was obtained in urea with 
creatinine (r =0.58) and uric acid(r =0.70).  Creatinine is 
positively correlated with urea (r =0.50) and uric acid (r 
=0.45) and it is significantly correlated with only sod (r 
=0.54) among oxidative stress parameters. Uric acid is 
significantly correlated with urea (r = 0.65) and 
creatinine (r = 0.45). GFR is significantly correlated with 
urea (r = -0.67), creatinine (r = -0.79) and uric acid (r = 
-0.67). GFR is highly significant with parameters of 
oxidative stress (SOD, CAT, GSH) and insignificant 
with (MDA). Catalase is significantly positively 
correlated with GSH (r = 0.51) and negatively correlated 
(significant) with MDA (r = -0.54). SOD is significantly 
correlated with creatinine (r =0.54) and with GSH (r= 
0.45). GSH is positively correlated with catalase(r =0.51) 
and SOD (r = 0.45), and negatively correlated with MDA 
(r = -0.36). MDA is negatively correlated with catalase (r 
=-0.54) and GSH (r = -0.35). 
 Group Mean Std. 
Deviation 
Std. Error 
Mean 
Sig. 2 
tailed 
urea Normal 15.200 3.49285 1.56205 0.000 
Patients 57.376 10.4696 2.34107 0.000 
creatinine Normal 0.9000 0.15811 0.07071 0.000 
patients 2.2800 0.65261 0.14593 0.000 
Uric acid Normal 3.9000 0.77460 0.34641 0.000 
patients 16.895 5.34578 1.19535 0.000 
GFR                 
                 
Normal  
Patient 
 119.8 
 3.447 
9.62808 
 20.8746 
4.30581 
4.66770 
0.000 
0.000 
Table 4: Descriptive statistics and independent T test 
Table 5: Correlations of ET-2 with oxidative stress and with the 
development of Renal Dysfunction 
Discussion  
The present study was designed to elucidate the role of 
endothelin 2 in renal dysfunction. Oxidative stress was 
measured in serum and ascitic fluid of patients of liver 
Traits Urea Creatinine  Uric 
Acid 
   CAT SOD GSH MDA 
GFR -0.7** -0.80** -0.7** -0.37* -0.38* -0.44* 0.06 
Urea   0.59** 0.7** 0.20 0.27 0.46* -0.21 
Creatinine     0.6** 0.07 0.45* 0.34 -0.04 
Uric acid       0.17 0.55** 0.39* -0.08 
CAT         0.03 0.51** -0.54** 
SOD           0.45** -0.005 
GSH             -0.36* 
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cirrhosis with ascites. The outcomes of CAT, GSH, SOD 
and MDA showed significant (P<0.05) differences in 
CAT, GSH, SOD and MDA levels in serum of patients 
of liver cirrhosis with ascites as compared to control 
group which was correlated with the work [14] in which 
significant difference of CAT, GSH, SOD and MDA 
level were observed in cirrhotic patients. Due to 
excessive ROS generation, body anti-oxidative defense 
mechanism gets activated to neutralize the ROS. As a 
result of anti oxidative defense mechanism, the level of 
GSH, CAT and GSH gets decreased while MDA is 
increased which signifies lipid per oxidation [15].  
Analysis of oxidative stress in serum and ascetic fluid 
of patients of liver cirrhosis showed significantly 
(P<0.05) elevated levels of catalase in serum of patients 
as compared to ascitic fluid of patients liver cirrhosis 
with ascites. Insignificant (P>0.05) difference in SOD 
and GSH was observed in serum as compared to fluid of 
patients. Elevated levels of catalase and MDA in serum 
as compared to the ascitic fluid of patients was may be 
due to less conversion of hydrogen peroxide into water 
and oxygen while insignificant MDA levels could be due 
to less lipid peroxidation and tissue is more susceptible 
to oxidative damage [16]. The findings were in line with 
work in which significant difference in anti-oxidative 
enzymes and MDA were obtained in liver cirrhosis [17].  
For the estimation of renal dysfunction, urea, creatinine 
and uric acid were assessed in serum while GFR was 
calculated through formula. The results showed 
significant (P<0.05) difference in urea creatinine, uric 
acid and GFR levels in patients as compared to normal 
individuals [18].  
Correlation of all renal parameters with oxidative 
stress parameters were also measured by Pearson 
correlation. Correlation was determined between 
oxidative stress parameters and renal indices. 
Correlation among the individual parameters of 
oxidative stress, showed positive and highly significant 
(P<0.05) correlation of CAT, SOD, MDA, and GSH 
levels with each other and with renal indices (urea, 
creatinine and uric acid) and insignificant difference 
with GFR. The findings were in line with work [19] in 
which significant difference in renal indices were 
obtained. In short, the present study speculates that 
increased production of ET-2 during vascular stress 
generated in patients of liver cirrhosis with ascites leads 
to the development of severe renal dysfunction. ET-2 
was detected in both serum and ascitic fluid of patients 
but it was not in significant amount to be quantified in 
serum and ascitic fluid of patients. But keeping in view 
the present study, As ET-2 was detected in both serum 
and ascitic fluid so, ET-2 can be considered as important 
key factor in the development of Renal dysfunction in 
patients of liver cirrhosis with ascites by the generation 
and provocation of oxidative stress in disease condition 
[20]. Considering the potentially important role of ET-2 
in the development of renal dysfunction in patients of 
liver cirrhosis with ascites, further study can be 
conducted to develop Endothelin receptor antagonists.  
To avoid the complication related to ET and to treat 
endothelial dysfunctioning, liver toxicity and other 
complications related to renal diseases. 
It was concluded from the outcomes of the present 
study that production of ET-2 in oxidative stress 
generated during liver cirrhosis which is an indicator of 
renal dysfunction in patients of liver cirrhosis and 
ascites.  As oxidative stress is malevolent process that 
can be an important negotiator of damage to cell 
structures and consequently leads to various disease 
states and ageing. So, ET-2 can be considered as an 
important novel biomarker of renal dysfunction in 
patients of liver cirrhosis with ascites. It was concluded 
from the outcomes of the present study that production 
of ET-2 in oxidative stress generated during liver 
cirrhosis which is an indicator of renal dysfunction in 
patients of liver cirrhosis and ascites.  As oxidative stress 
is malevolent process that can be an important 
negotiator of damage to cell structures and consequently 
leads to various disease states and ageing. So, ET-2 can 
be considered as an important novel biomarker of renal 
dysfunction in patients of liver cirrhosis with ascites. 
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